Next-generation sequencing of USP8 wild-type ACTHomas has revealed TP53 pathogenic variants that are associated with larger and invasive tumors including tumors from patients with Nelson’s syndrome or pituitary carcinomas (58, 59). Here, USP8 is linked to ACTH-producing pituitary gland adenoma.